Long-term use of statins reduce colorectal cancer risk

A systematic review of the medical literature supports the hypothesis that statins, cholesterol-lowering drugs used to prevent cardiac problems, are associated with reduced risk of colon and rectal cancers. A comprehensive analysis by investigators at the University of Michigan at Ann Arbor, included 22 scientific studies with more than 2.5 million combined participants.

“Statin use was associated with a statistically significant reduction in colorectal cancer,” explained Jewel Samadder, M.D., MSc. The relative risk was 0.88 (95% CI 0.84-0.93;>

“Observational studies have suggested that long-term use of statins is associated with reduced risk of several cancers, including breast, prostate, lung, pancreas and liver. Our findings suggest that randomized controlled trials designed to test the hypothesis that statins reduce the risk of colorectal cancer are warranted,” added Dr. Samadder.

Source: University of Michigan